Broncus Holding Corp

02216

Company Profile

  • Business description

    Broncus Holding Corp is focused on provision of interventional treatment of Chronic Obstructive Pulmonary Disease and lung cancer. It engages in the field of Interventional Pulmonology, providing solutions for lung diseases in China and globally. Its products portfolio includes the InterVapor Thermal Vapor Treatment System the only implantable medical device to treat COPD; BroncAblate Radiofrequency Ablation System the transbronchial interventional treatment product for lung cancer; Targeted Lung Denervation Radiofrequency Ablation System the self-developed targeted radiofrequency ablation system in China to reduce the risk of acute exacerbation of COPD.

  • Contact

    No. 88 Jiangling Road, Xixing Street
    Room 801, 8th Floor, Building 8
    Binjiang District
    Hangzhou
    CHN

    T: +86 57186595016

    https://www.broncus.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    208

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,571.4040.30-0.47%
CAC 407,831.9978.50-0.99%
DAX 4023,909.38213.02-0.88%
Dow JONES (US)41,860.44816.80-1.91%
FTSE 1008,722.8563.61-0.72%
HKSE23,544.31283.47-1.19%
NASDAQ18,872.64270.07-1.41%
Nikkei 22536,985.87313.11-0.84%
NZX 50 Index12,662.2540.85-0.32%
S&P 5005,844.6195.85-1.61%
S&P/ASX 2008,348.7038.10-0.45%
SSE Composite Index3,380.197.39-0.22%

Market Movers